ストックスクリーナーアプリを入手
12.16
4.56%
0.53
前日終値:
$11.63
開ける：
$11.81
24時間の取引高:
2.15M
Relative Volume:
0.80
時価総額：
$958.07M
収益：
$65,400
当期純損益:
$-46.34M
株価収益率:
-13.22
EPS:
-0.92
ネットキャッシュフロー:
$-38.74M
1週間 パフォーマンス:
-2.95%
1か月 パフォーマンス:
+24.34%
6か月 パフォーマンス:
+4.92%
1年 パフォーマンス:
+47.93%
1日の値動き範囲:
$11.74
$12.29
1週間の範囲:
$11.62
$13.02
52週間の値動き範囲:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
名前
CorMedix Inc
セクター
電話
908-517-9500
住所
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
12.16 | 916.32M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | アップグレード | D. Boral Capital | Hold → Buy |
| 2025-06-30 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-07 | 開始されました | Leerink Partners | Outperform |
| 2025-01-13 | 開始されました | D. Boral Capital | Buy |
| 2024-08-26 | 開始されました | Rodman & Renshaw | Buy |
| 2023-08-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-02-17 | 開始されました | Needham | Buy |
| 2020-09-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-09-21 | 開始されました | Truist | Buy |
| 2019-12-18 | 開始されました | B. Riley FBR | Buy |
| 2019-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-12-06 | 開始されました | ROTH Capital | Buy |
| 2017-09-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-08-10 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-05-05 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-11-11 | 繰り返されました | FBR & Co. | Outperform |
| 2016-03-17 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-03 | 開始されました | FBR Capital | Outperform |
| 2015-11-16 | 繰り返されました | ROTH Capital | Neutral |
| 2015-10-29 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 繰り返されました | ROTH Capital | Buy |
| 2011-10-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
CorMedix Inc (CRMD) 最新ニュース
Cormedix director Dunton sells $260k in shares - Investing.com
INSM Stock Up 78% in 6 Months: Here's What You Need to Know - Finviz
Surprises Report: What sentiment indicators say about CorMedix Inc stockJuly 2025 Highlights & Community Driven Trade Alerts - moha.gov.vn
Kyverna Therapeutics Stock Up 41% in a Month: Here's Why - The Globe and Mail
RARE, MREO Tank as Osteogenesis Study Fails to Meet Primary Endpoint - The Globe and Mail
CorMedix price target raised to $18 from $17 at H.C. Wainwright - MSN
Can CorMedix's Melinta acquisition aid growth beyond DefenCath? - MSN
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026? - Finviz
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? - sharewise.com
Responsive Playbooks and the CRMD Inflection - Stock Traders Daily
Meme Stocks: Is Adyen NV 1N8 stock attractive post correctionEarnings Recap Report & Safe Capital Allocation Plans - moha.gov.vn
CorMedix (CRMD): Evaluating Valuation After a Strong Multi‑Year Share Price Run - Sahm
CorMedix (CRMD): Assessing Valuation After a Strong Multi‑Year Share Price Run - Yahoo Finance
Why CorMedix could be the biopharma name to watch early in 2026 - MSN
CorMedix Builds a Real Revenue Story as DefenCath Adoption Accelerates - Investing.com
CorMedix Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Why CorMedix Could be the Biopharma Name to Watch Early in 2026 - sharewise.com
CorMedix Inc.'s (NASDAQ:CRMD) 28% Jump Shows Its Popularity With Investors - simplywall.st
CorMedix CEO Todisco sells $360,000 in CRMD stock - Investing.com India
CorMedix CEO Todisco sells $360,000 in CRMD stock By Investing.com - Investing.com Nigeria
CRMD SEC FilingsCormedix 10-K, 10-Q, 8-K Forms - Stock Titan
How CorMedix Inc. stock compares to market leadersWeekly Profit Summary & Fast Moving Stock Trade Plans - Улправда
Can CorMedix Inc. stock surprise with earnings upside2025 Growth vs Value & Weekly Breakout Watchlists - moha.gov.vn
Bear Alert: How CorMedix Inc. stock compares to market leadersMarket Growth Summary & Free Technical Confirmation Trade Alerts - Улправда
How rising interest rates impact CorMedix Inc. stockGDP Growth & Real-Time Sentiment Analysis - Улправда
How CorMedix Inc. stock reacts to global recession fears2025 Winners & Losers & Short-Term Swing Trade Alerts - Улправда
CEO Todisco Sells 30,000 ($360K) Of CorMedix Inc [CRMD] - TradingView — Track All Markets
Income Plays: Can CorMedix Inc. stock surprise with earnings upsideWeekly Trade Review & Accurate Intraday Trading Signals - Улправда
Will CorMedix Inc. (19KA) stock benefit from infrastructure billJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? - Yahoo Finance
Will CorMedix Inc. (19KA) stock gain from lower interest rates2025 Historical Comparison & Fast Exit/Entry Strategy Plans - DonanımHaber
Sentiment Recap: Will CorMedix Inc. (19KA) stock gain from lower interest ratesJuly 2025 Retail & Safe Entry Point Identification - DonanımHaber
Is CorMedix Inc. stock a top pick in earnings season2025 Market Outlook & Smart Investment Allocation Insights - DonanımHaber
Will CorMedix Inc. (19KA) stock hit analyst forecastsWeekly Trade Review & Weekly High Potential Stock Alerts - DonanımHaber
Can CorMedix Inc. (19KA) stock surprise with quarterly resultsQuarterly Market Summary & AI Powered Buy/Sell Recommendations - ulpravda.ru
Breakout Move: How sustainable is CorMedix Inc. stock dividend payoutWeekly Stock Analysis & Risk Controlled Stock Alerts - Улправда
CorMedix announces interim results for DefenCath - TipRanks
Why Is CorMedix Stock Rising Today? - Asianet Newsable
CorMedix Says Interim DefenCath Study Data Show Fewer Infections - marketscreener.com
Cormedix reports positive data from real world study of Defencath - marketscreener.com
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath - The Manila Times
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - Yahoo Finance
(CRMD) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
CRMD up more than 40% YTD: Time to buy, sell or hold the stock? - MSN
Cormedix Director Makes a Significant Stock Sale! - TipRanks
CorMedix Q3 2025 Earnings Preview - MSN
CorMedix Inc (CRMD) 財務データ
収益
当期純利益
現金流量
EPS
0.57%
大文字化:
|
ボリューム (24 時間):